×
About 36,230 results

Chinese Cities Ease Curbs but Full Zero-COVID Exit Seen Some Way Off
https://www.medscape.com/viewarticle/984966

Dec 5th, 2022 - BEIJING (Reuters) - More Chinese cities including Urumqi in the far west announced an easing of coronavirus curbs on Sunday as China tries to make its zero-COVID policy more targeted and less onerous after unprecedented protests against restrictions last weekend. Urumqi, the capital of the Xinjiang region and where the protests first erupted, will reopen malls, markets, restaurants and other ve...

Pfizer Applies for FDA Authorization for Omicron-Retooled Vaccine Booster in Kids Under 5
https://www.medscape.com/viewarticle/984977

Dec 5th, 2022 - (Reuters) -Pfizer Inc and its German partner BioNTech SE said on Monday they have submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization of their Omicron-adapted COVID-19 vaccine booster for children aged 6 months through 4 years. If authorized, children would receive the primary series consisting of two doses of the original Pfizer-BioNTech COVI...

Pandemic Delayed Treatment in Patients With CTCL, Study Finds
https://www.medscape.com/viewarticle/984982

Dec 5th, 2022 - The early stages of the COVID-19 pandemic caused an average treatment delay of 3.2 months for 53% of patients with cutaneous T-cell lymphoma (CTCL), results from a retrospective study of nine international centers showed. However, among patients with CTCL diagnosed with COVID-19 during that time, no cases were acquired from outpatient visits. "Delays in therapy for patients with cutaneous lymph...

Medically Speaking, 2022 Was the Best Year Yet for Children
https://www.medscape.com/viewarticle/984793

Dec 5th, 2022 - Headlines from earlier in the fall were grim: Thanks to the COVID-19 pandemic, life expectancy in the United States has fallen for 2 years running. Last year, according to health officials, the average American newborn could hope to reach 76.1 years, down from 79 years in 2019. So far, so bad. But the headlines don't tell the full story, which is much less dire. In fact, 2022 is the best year i...

Pfizer to Invest More Than $2.5 Billion to Expand European Manufacturing
https://www.medscape.com/viewarticle/984908

Dec 5th, 2022 - NEW YORK (Reuters) - Pfizer Inc is investing more than $2.5 billion at its drug making plants in Belgium and Ireland, gearing up to launch new products it hopes can replace lost revenue as patents expire and COVID-19 vaccine sales decline. The drugmaker said on Friday it plans to spend more than 1.2 billion euros ($1.26 billion) to expand its Puurs, Belgium, manufacturing site, matching the inv...

How Many People Might Die, and Why, if China Loosens COVID Restrictions
https://www.medscape.com/viewarticle/984964

Dec 5th, 2022 - SHANGHAI (Reuters) - China has started taking steps to ease its zero-COVID policy, fuelling a mix of relief and worry as the public waits to see the health consequences, and impact on the medical system, of a full-blown exit. Researchers have analysed how many deaths the country could see if it pivots to a full reopening, with most pointing to the country's relatively low vaccination rates and ...

Relief and Worry as Major Chinese Cities Ease COVID Curbs
https://www.medscape.com/viewarticle/984900

Dec 2nd, 2022 - BEIJING (Reuters) - Further easing of COVID-19 testing requirements and quarantine rules in some Chinese cities was met with a mix of relief and worry on Friday, as hundreds of millions await an expected shift in national virus policies after widespread social unrest. The looser measures were welcomed by workers frustrated by three years of economically damaging curbs but have jolted others who...

COVID Vax Prevents Death in Children Regardless of Variant
https://www.medscape.com/viewarticle/984954

Dec 2nd, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 vaccines retained the ability to prevent deaths from COVID-19 in children and adolescents regardless of the dominant circulating variant, in a new study. The vaccine's effectiveness against infection in the short term has been established, as has the waning effectiveness of the vaccine ...

Mistakes at UK COVID Testing Lab May Have Led to Deaths of 20 People
https://www.medscape.com/viewarticle/984802

Dec 2nd, 2022 - LONDON (Reuters) - England's government agency responsible for responding to public health emergencies said mistakes at a testing laboratory led to misreporting of tens of thousands of positive COVID-19 cases as negative and may have resulted in the deaths of about 20 people. Britain has one of the highest coronavirus death tolls in the world, with more than 177,000 deaths since the pandemic st...

Virtual Yoga Program Appears to Improve IBS Symptoms, Fatigue, Stress
https://www.medscape.com/viewarticle/984961

Dec 2nd, 2022 - An online yoga program appears to be effective, feasible, and safe for patients with irritable bowel syndrome (IBS), according to a new report. Participants reported a decrease in IBS-related symptoms and improvements in quality of life, fatigue, and perceived stress. "IBS affects upwards of 15%-20% of the North American population, and despite our advances in the area, we have very limited opt...

'Doctor Mike,' With 10M+ Viewers, Shares His Social Media Tips
https://www.medscape.com/viewarticle/982012

Dec 1st, 2022 - This transcript has been edited for clarity. Robert Glatter, MD: Welcome. I'm Dr Robert Glatter, medical advisor for Medscape Emergency Medicine. Today, we have Dr Mikhail Varshavski, otherwise known as "Doctor Mike," who is a family medicine physician and well-known social media medical influencer. He's joining us to discuss how he has spent the past several years debunking medical misinformat...

Moderna Exec Says COVID Trials Improved Diversity Recruiting
https://www.medscape.com/viewarticle/984827

Dec 1st, 2022 - NEW YORK (Reuters) - Moderna Inc's top scientist said on Tuesday that the vaccine maker has learned how to better recruit from diverse populations for its clinical trials from running its COVID-19 vaccine studies. Moderna Chief Medical Officer Paul Burton, speaking at the Reuters NEXT conference in New York, said that in 2020 the company needed to slow enrollment in its initial COVID-19 vaccine...

China to Allow Home Quarantine for Some Infected With COVID: Sources
https://www.medscape.com/viewarticle/984833

Dec 1st, 2022 - HONG KONG (Reuters) - China will allow some people who test positive for COVID-19 to quarantine at home, among supplementary measures to be announced in coming days, two sources with knowledge of the matter told Reuters. Home isolation for the infected would be a significant change in China's quarantine protocols. Earlier this year, entire communities were locked down, sometimes for weeks, afte...

Chinese Vice Premier Urges Improvements in COVID Measures as Pathogenicity Weakens
https://www.medscape.com/viewarticle/984831

Dec 1st, 2022 - BEIJING (Reuters) - Chinese Vice Premier Sun Chunlan called for further efforts to improve COVID-19 prevention and control measures, urging "optimisation" of testing, treatment and quarantine policies, as the virus weakens in pathogenicity, according to state media. Her remarks come as cities across China take a more targeted approach to tackle outbreaks, fine-tuning 20 new measures released by...

Buzzy Lancet Long COVID Paper Under Investigation for 'Data Errors'
https://www.medscape.com/viewarticle/984858

Dec 1st, 2022 - Editor's note: Find the latest long COVID news and guidance in Medscape's Long COVID Resource Center. An early and influential paper on long COVID that appeared in The Lancet has been flagged with an expression of concern while the journal investigates "data errors" brought to light by a reader. An editorial that accompanied the paper when it was published in January of last year described it a...

Former President Bill Clinton Says He Has Mild Case of COVID
https://www.medscape.com/viewarticle/984877

Dec 1st, 2022 - Former President Bill Clinton has tested positive for COVID-19. "I've had mild symptoms, but I'm doing fine overall and keeping myself busy at home," Clinton, 76, wrote on Twitter on Wednesday. "I'm grateful to be vaccinated and boosted, which has kept my case mild, and I urge everyone to do the same, especially as we move into the winter months." https://twitter.com/BillClinton/status/15980319...

CDC Awards Over $3 Billion to Strengthen US Public Health Infrastructure
https://www.medscape.com/viewarticle/984806

Dec 1st, 2022 - (Reuters) - The Centers for Disease Control and Prevention (CDC) said on Tuesday it is awarding more than $3 billion to help strengthen public health workforce and infrastructure across the United States after the COVID-19 pandemic put severe stress on them. The public health agency's funding includes $3 billion from the American Rescue Plan announced by President Joe Biden's administration las...

Twitter Rolls Back COVID Misinformation Policy
https://www.medscape.com/viewarticle/984807

Dec 1st, 2022 - (Reuters) -Twitter Inc has rolled back a policy that was aimed at tackling misinformation related to COVID-19 on the social media platform, lending itself to the risk of a potential surge in false claims even as cases rise in China and some parts of the world. The move also comes amid concerns of Twitter's ability to fight misinformation after it let go about half of its staff, including those ...

China Reports Slight Drop in New COVID Cases for November 29; Beijing Cases Rise
https://www.medscape.com/viewarticle/984809

Dec 1st, 2022 - SHANGHAI (Reuters) - China reported 37,828 new COVID-19 infections on Nov. 29, of which 4,288 were symptomatic and 33,540 were asymptomatic, the National Health Commission said on Wednesday. That is compared with 38,645 new cases a day earlier – 3,624 symptomatic and 35,021 asymptomatic infections, which China counts separately. Excluding imported infections, China reported 37,612 new local cas...

FDA Pulls US Authorization for Eli Lilly's COVID Drug Bebtelovimab
https://www.medscape.com/viewarticle/984823

Dec 1st, 2022 - (Reuters) -Eli Lilly and Co's COVID-19 drug bebtelovimab is not currently authorized for emergency use in the United States, the Food and Drug Administration said, citing it is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron. Wednesday's announcement takes away authorization from the last COVID-19 monoclonal antibody treatment, leaving Pfizer Inc's antiviral drug ...